Institutional Biosafety Committee (IBC)
The goal: eliminate or reduce the potential exposure of personnel or the environment. "Biohazardous materials" are defined as materials of biological origin that have the capacity to produce deleterious effects on humans or animals. These include:
- Recombinant DNA molecules
- Microorganisms classified in various Risk Groups (RG-1, RG-2, RG-3, or RG-4) and their biological products
- Specimens known to (or reasonably expected to) contain human pathogens
- Hazardous microorganisms
- Combinations of or waste derived from these
This responsibility is described in the IBC Procedure Manual 2019. The UMKC IBC is the IBC-of-record for research at affiliated Kansas City institutions, including University Health. The IBC and its Biosafety Officers (BSOs) are responsible to evaluate and monitor research and teaching at UMKC and the affiliated institutions for biological safety considerations.
Essential Information
UMKC IBC Human Cell Line Policy (PDF)
Changes to Federal Oversight of Human Gene Transfer
August 2018: The NIH Office of Science Policy no longer requires review by its Recombinant DNA Advisory Committee (RAC) of proposed HGT protocols or reports.
For details, see the NIH Director's Statement.
- UMKC Biosafety Manual (DOCX)
- NIH Guidelines 2019 for Research Involving Recombinant DNA Molecules (PDF)
IBC Community Membership
We are looking for community members to serve on UMKC's Institutional Biosafety Committee (IBC). By federal regulations, the IBC must have two members who are not affiliated with the University.
If you are interested in becoming a member, contact the Research Compliance Office at 816-235-1764.
Attend IBC Meetings
Meetings are held quarterly in the Health Sciences Building.
Upcoming Meetings
February 4, 2025
Material submission deadline: January 21, 2025
May 7, 2025
Material submission deadline: April 22, 2025
August 5, 2025
Material submission deadline: July 22, 2025
November 11, 2025
Material submission deadline: October 28, 2025